Antiepileptika - alfabetisk liste
Sist oppdatert: Sist revidert:
Spc'er og Norsk Legemiddelhåndbok + referanselisten
- Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies. Neurology. 2016 Jul 19;87(3):314-23 . pmid:27335114 PubMed
- Golyala A, Kwan P. Drug development for refractory epilepsy: The past 25 years and beyond. Seizure. 2017 Jan;44:147-156. doi: 10.1016/j.seizure.2016.11.022. Epub 2016 Dec 6. Review. PMID: 28017578 PubMed
- Santulli L, Coppola A, Balestrini S, Striano S. The challenges of treating epilepsy with 25 antiepileptic drugs. Pharmacol Res. 2016 May;107:211-219. doi: 10.1016/j.phrs.2016.03.016. Epub 2016 Mar 16. Review. PMID: 26995307 PubMed
- Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harb Perspect Med. 2016 May 2;6(5). pii: a022780. doi: 10.1101/cshperspect.a022780. Review. PMID: 26801895 PubMed
- Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22(1):27-47. Review. PMID: 18072813 PubMed
- Burns ML, Baftiu A, Opdal MS, Johannessen SI, Landmark CJ. Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability. Ther Drug Monit. 2016 Jun;38(3):350-7. doi: 10.1097/FTD.0000000000000272. PMID: 26751267 PubMed
- Baftiu A, Johannessen Landmark C, Rusten IR, Feet SA, Johannessen SI, Larsson PG. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol. 2016 Oct;72(10):1245-1254. doi: 10.1007/s00228-016-2092-3. Epub 2016 Jul 13. Erratum in: Eur J Clin Pharmacol. 2017 Apr 7;:. Eur J Clin Pharmacol. 2017 Jun;73(6):791-792. PMID: 27411937 PubMed
- Landmark CJ, Johannessen SI. Safety aspects of antiepileptic drugs--focus on pharmacovigilance. Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):11-20. doi: 10.1002/pds.2269. Epub 2011 Nov 8. Review. PMID: 22069221 PubMed
- Johannessen Landmark C, Baftiu A, Burns ML, Mevåg MA, Feet SA, Reiter L, Johannessen SI. Bedre behandling med antiepileptika for den enkelte pasient! Norsk Farmaceutisk Tidsskrift, 2015, 2, 15-20
- Legemiddelverket. http://www.legemiddelverket.no/Nyheter/Bivirkninger/Sider/Epilepsimidlet-retigabin-kan-gi-pigmentforandringer.aspx